Standout Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 2023 2026 2024146
  1. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (2023)
    Simon B. Drysdale, Katrina Cathie et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Lung microbiome: new insights into the pathogenesis of respiratory diseases
2024 Standout
Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
2024 Standout
1 intermediate paper

Works of Helen Hill being referenced

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens
2019

Author Peers

Author Last Decade Papers Cites
Helen Hill 221 100 9 84 16 393
Jack A. Barnett 132 66 39 64 15 406
Rolf Schloesser 175 114 7 80 26 402
J. W. Millar 183 113 1 77 21 452
GeraldW. Fischer 155 35 1 66 11 430
Edwin J. Smith 141 138 7 104 20 442
Nobumasa Aoki 190 91 11 56 25 419
Anan Wattanathum 158 82 18 38 23 372
Michaëla A. M. Huson 185 100 16 44 20 373
Scott Harkonen 98 68 15 91 11 413
Haruji Nakamura 188 21 14 67 14 368

All Works

Loading papers...

Rankless by CCL
2026